vs
Side-by-side financial comparison of HALOZYME THERAPEUTICS, INC. (HALO) and Noble Corp plc (NE). Click either name above to swap in a different company.
Noble Corp plc is the larger business by last-quarter revenue ($764.4M vs $451.8M, roughly 1.7× HALOZYME THERAPEUTICS, INC.). Noble Corp plc runs the higher net margin — 11.3% vs -31.3%, a 42.7% gap on every dollar of revenue. On growth, HALOZYME THERAPEUTICS, INC. posted the faster year-over-year revenue change (51.6% vs -17.6%). HALOZYME THERAPEUTICS, INC. produced more free cash flow last quarter ($217.6M vs $35.4M). Over the past eight quarters, HALOZYME THERAPEUTICS, INC.'s revenue compounded faster (51.9% CAGR vs 9.5%).
Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment.
Barnes & Noble Booksellers is an American bookseller with the largest number of retail outlets in the United States. The company operates approximately 700+ retail stores across the United States.
HALO vs NE — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $451.8M | $764.4M |
| Net Profit | $-141.6M | $86.6M |
| Gross Margin | 82.6% | — |
| Operating Margin | -20.6% | 5.6% |
| Net Margin | -31.3% | 11.3% |
| Revenue YoY | 51.6% | -17.6% |
| Net Profit YoY | -203.3% | -10.4% |
| EPS (diluted) | $-1.13 | $0.54 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $451.8M | $764.4M | ||
| Q3 25 | $354.3M | $798.0M | ||
| Q2 25 | $325.7M | $848.7M | ||
| Q1 25 | $264.9M | $874.5M | ||
| Q4 24 | $298.0M | $927.3M | ||
| Q3 24 | $290.1M | $800.5M | ||
| Q2 24 | $231.4M | $692.8M | ||
| Q1 24 | $195.9M | $637.1M |
| Q4 25 | $-141.6M | $86.6M | ||
| Q3 25 | $175.2M | $-21.1M | ||
| Q2 25 | $165.2M | $42.9M | ||
| Q1 25 | $118.1M | $108.3M | ||
| Q4 24 | $137.0M | $96.6M | ||
| Q3 24 | $137.0M | $61.2M | ||
| Q2 24 | $93.2M | $195.0M | ||
| Q1 24 | $76.8M | $95.5M |
| Q4 25 | 82.6% | — | ||
| Q3 25 | 84.4% | — | ||
| Q2 25 | 85.8% | — | ||
| Q1 25 | 81.7% | — | ||
| Q4 24 | 85.9% | — | ||
| Q3 24 | 83.0% | — | ||
| Q2 24 | 82.9% | — | ||
| Q1 24 | 85.5% | — |
| Q4 25 | -20.6% | 5.6% | ||
| Q3 25 | 61.5% | 6.3% | ||
| Q2 25 | 62.2% | 15.9% | ||
| Q1 25 | 53.4% | 21.4% | ||
| Q4 24 | 58.9% | 18.4% | ||
| Q3 24 | 56.3% | 14.4% | ||
| Q2 24 | 50.7% | 30.3% | ||
| Q1 24 | 48.8% | 16.9% |
| Q4 25 | -31.3% | 11.3% | ||
| Q3 25 | 49.5% | -2.6% | ||
| Q2 25 | 50.7% | 5.1% | ||
| Q1 25 | 44.6% | 12.4% | ||
| Q4 24 | 46.0% | 10.4% | ||
| Q3 24 | 47.2% | 7.6% | ||
| Q2 24 | 40.3% | 28.1% | ||
| Q1 24 | 39.2% | 15.0% |
| Q4 25 | $-1.13 | $0.54 | ||
| Q3 25 | $1.43 | $-0.13 | ||
| Q2 25 | $1.33 | $0.27 | ||
| Q1 25 | $0.93 | $0.67 | ||
| Q4 24 | $1.06 | $0.56 | ||
| Q3 24 | $1.05 | $0.40 | ||
| Q2 24 | $0.72 | $1.34 | ||
| Q1 24 | $0.60 | $0.66 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $133.8M | $471.4M |
| Total DebtLower is stronger | $2.1B | — |
| Stockholders' EquityBook value | $48.8M | $4.5B |
| Total Assets | $2.5B | $7.5B |
| Debt / EquityLower = less leverage | 43.89× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $133.8M | $471.4M | ||
| Q3 25 | $419.7M | $477.9M | ||
| Q2 25 | $61.9M | $338.2M | ||
| Q1 25 | $176.3M | $303.8M | ||
| Q4 24 | $115.8M | $247.3M | ||
| Q3 24 | $154.3M | $391.9M | ||
| Q2 24 | $187.9M | $162.9M | ||
| Q1 24 | $164.6M | $212.5M |
| Q4 25 | $2.1B | — | ||
| Q3 25 | $1.5B | — | ||
| Q2 25 | $1.5B | — | ||
| Q1 25 | $1.5B | — | ||
| Q4 24 | $1.5B | — | ||
| Q3 24 | $1.5B | — | ||
| Q2 24 | $1.5B | — | ||
| Q1 24 | $1.5B | — |
| Q4 25 | $48.8M | $4.5B | ||
| Q3 25 | $503.9M | $4.5B | ||
| Q2 25 | $332.7M | $4.6B | ||
| Q1 25 | $482.3M | $4.7B | ||
| Q4 24 | $363.8M | $4.7B | ||
| Q3 24 | $452.7M | $4.7B | ||
| Q2 24 | $289.4M | $4.0B | ||
| Q1 24 | $177.8M | $3.9B |
| Q4 25 | $2.5B | $7.5B | ||
| Q3 25 | $2.2B | $7.6B | ||
| Q2 25 | $2.1B | $7.7B | ||
| Q1 25 | $2.2B | $7.9B | ||
| Q4 24 | $2.1B | $8.0B | ||
| Q3 24 | $2.1B | $8.0B | ||
| Q2 24 | $2.0B | $5.6B | ||
| Q1 24 | $1.8B | $5.4B |
| Q4 25 | 43.89× | — | ||
| Q3 25 | 3.00× | — | ||
| Q2 25 | 4.54× | — | ||
| Q1 25 | 3.13× | — | ||
| Q4 24 | 4.14× | — | ||
| Q3 24 | 3.32× | — | ||
| Q2 24 | 5.19× | — | ||
| Q1 24 | 8.44× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $219.0M | $187.1M |
| Free Cash FlowOCF − Capex | $217.6M | $35.4M |
| FCF MarginFCF / Revenue | 48.2% | 4.6% |
| Capex IntensityCapex / Revenue | 0.3% | 19.9% |
| Cash ConversionOCF / Net Profit | — | 2.16× |
| TTM Free Cash FlowTrailing 4 quarters | $644.6M | $432.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $219.0M | $187.1M | ||
| Q3 25 | $178.6M | $277.1M | ||
| Q2 25 | $99.7M | $216.4M | ||
| Q1 25 | $154.2M | $271.1M | ||
| Q4 24 | $178.5M | $136.2M | ||
| Q3 24 | $115.4M | $283.8M | ||
| Q2 24 | $55.8M | $106.8M | ||
| Q1 24 | $129.4M | $128.7M |
| Q4 25 | $217.6M | $35.4M | ||
| Q3 25 | $175.6M | $139.5M | ||
| Q2 25 | $98.1M | $99.8M | ||
| Q1 25 | $153.3M | $157.5M | ||
| Q4 24 | $175.4M | $-4.4M | ||
| Q3 24 | $113.9M | $156.8M | ||
| Q2 24 | $53.2M | $-34.3M | ||
| Q1 24 | $125.9M | $-37.9M |
| Q4 25 | 48.2% | 4.6% | ||
| Q3 25 | 49.6% | 17.5% | ||
| Q2 25 | 30.1% | 11.8% | ||
| Q1 25 | 57.9% | 18.0% | ||
| Q4 24 | 58.9% | -0.5% | ||
| Q3 24 | 39.3% | 19.6% | ||
| Q2 24 | 23.0% | -4.9% | ||
| Q1 24 | 64.3% | -6.0% |
| Q4 25 | 0.3% | 19.9% | ||
| Q3 25 | 0.9% | 17.3% | ||
| Q2 25 | 0.5% | 13.7% | ||
| Q1 25 | 0.4% | 13.0% | ||
| Q4 24 | 1.0% | 15.2% | ||
| Q3 24 | 0.5% | 15.9% | ||
| Q2 24 | 1.1% | 20.4% | ||
| Q1 24 | 1.8% | 26.2% |
| Q4 25 | — | 2.16× | ||
| Q3 25 | 1.02× | — | ||
| Q2 25 | 0.60× | 5.05× | ||
| Q1 25 | 1.31× | 2.50× | ||
| Q4 24 | 1.30× | 1.41× | ||
| Q3 24 | 0.84× | 4.64× | ||
| Q2 24 | 0.60× | 0.55× | ||
| Q1 24 | 1.68× | 1.35× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HALO
| Royalty | $258.0M | 57% |
| Products | $122.7M | 27% |
| Proprietary Products Sales | $59.6M | 13% |
| Device Partnered Products | $12.9M | 3% |
NE
| Floaters | $559.8M | 73% |
| Jackups | $145.5M | 19% |
| Service Other | $59.1M | 8% |
